Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COCH Envoy Medical	$1.46 -1.4%	$1.50	$1.21 ▼ $3.99	$31.85M	2.21	17,016 shs	4,555 shs
CODX Co-Diagnostics	$0.27 +0.9%	$0.27	$0.23 ▼ $2.23	$8.83M	0.51	839,846 shs	1.10 million shs
POCI Precision Optics	$4.73 +1.7%	$4.75	$3.47 ▼ $6.59	$35.65M	0.3	5,659 shs	1,967 shs
PYPD PolyPid	$3.43 -1.7%	$3.49	$2.30 ▼ $3.93	$55.48M	1.4	87,166 shs	37,480 shs

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COCH Envoy Medical	-1.35%	-0.68%	-10.98%	-13.10%	-47.10%
CODX Co-Diagnostics	+2.08%	+7.58%	-0.64%	-11.53%	-78.07%
POCI Precision Optics	+1.72%	+2.60%	-5.89%	+4.65%	-11.59%
PYPD PolyPid	-1.72%	+6.85%	-2.00%	+25.18%	-1.72%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
COCH Envoy Medical	3.4578 of 5 stars	3.5	5.0	0.0	2.7	3.3	0.0
CODX Co-Diagnostics	4.5803 of 5 stars	3.5	5.0	4.4	3.3	0.0	1.3
POCI Precision Optics	0.7446 of 5 stars	0.0	3.0	0.0	3.8	0.8	0.0
PYPD PolyPid	3.0198 of 5 stars	3.6	5.0	0.0	2.4	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COCH Envoy Medical	3.00	Buy	$9.25	533.56% Upside
CODX Co-Diagnostics	3.00	Buy	$5.50	1,972.34% Upside
POCI Precision Optics	0.00	N/A	N/A	N/A
PYPD PolyPid	3.17	Buy	$12.40	261.52% Upside

Current Analyst Ratings Breakdown

Latest CODX, PYPD, POCI, and COCH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/14/2025	PYPD PolyPid	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$15.00 ➝ $13.00
8/14/2025	PYPD PolyPid	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
8/13/2025	PYPD PolyPid	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$13.00
6/18/2025	PYPD PolyPid	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$12.00 ➝ $9.00
6/17/2025	PYPD PolyPid	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Outperform ➝ Market Outperform	$16.00 ➝ $14.00
6/9/2025	PYPD PolyPid	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$11.00 ➝ $13.00
6/5/2025	PYPD PolyPid	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$9.00
6/2/2025	PYPD PolyPid	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Buy	$11.00
5/27/2025	COCH Envoy Medical	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$9.25 ➝ $9.50

(Data available from 8/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COCH Envoy Medical	$220K	142.81	N/A	N/A	($1.39) per share	-1.05
CODX Co-Diagnostics	$3.91M	2.28	N/A	N/A	$1.70 per share	0.16
POCI Precision Optics	$19.10M	1.90	N/A	N/A	$1.66 per share	2.85
PYPD PolyPid	N/A	N/A	N/A	N/A	$0.75 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COCH Envoy Medical	-$20.80M	-$1.43	N/A	N/A	N/A	-10,961.26%	N/A	-236.14%	N/A
CODX Co-Diagnostics	-$37.64M	-$1.17	N/A	N/A	N/A	-1,025.45%	-60.16%	-52.69%	N/A
POCI Precision Optics	-$2.95M	-$0.89	N/A	∞	N/A	-32.84%	-54.03%	-32.48%	9/29/2025 (Estimated)
PYPD PolyPid	-$29.02M	-$4.30	N/A	∞	N/A	N/A	-1,042.66%	-167.87%	N/A

Latest CODX, PYPD, POCI, and COCH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	CODX Co-Diagnostics	-$0.25	-$0.23	+$0.02	-$0.23	$0.30 million	$0.16 million
8/13/2025	Q2 2025	PYPD PolyPid	-$0.53	-$0.78	-$0.25	-$0.78	N/A	N/A
7/31/2025	Q2 2025	COCH Envoy Medical	-$0.29	-$0.32	-$0.03	-$0.32	$0.07 million	$0.08 million
5/15/2025	Q3 2025	POCI Precision Optics	N/A	-$0.30	N/A	-$0.30	N/A	$4.19 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
COCH Envoy Medical	N/A	N/A	N/A	N/A	N/A
CODX Co-Diagnostics	N/A	N/A	N/A	N/A	N/A
POCI Precision Optics	N/A	N/A	N/A	N/A	N/A
PYPD PolyPid	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
COCH Envoy Medical	N/A	0.94	0.74
CODX Co-Diagnostics	N/A	4.43	4.23
POCI Precision Optics	0.11	1.99	1.26
PYPD PolyPid	4.43	0.71	0.71

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
COCH Envoy Medical	8.59%
CODX Co-Diagnostics	14.99%
POCI Precision Optics	13.71%
PYPD PolyPid	26.47%

Insider Ownership

Company	Insider Ownership
COCH Envoy Medical	58.90%
CODX Co-Diagnostics	8.40%
POCI Precision Optics	12.99%
PYPD PolyPid	24.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
COCH Envoy Medical	34	21.52 million	8.85 million	Not Optionable
CODX Co-Diagnostics	100	33.57 million	30.75 million	Optionable
POCI Precision Optics	80	7.67 million	6.67 million	Not Optionable
PYPD PolyPid	80	15.90 million	11.97 million	No Data

CODX, PYPD, POCI, and COCH Headlines

Recent News About These Companies

PolyPid's (PYPD) "Buy" Rating Reaffirmed at HC Wainwright

August 15 at 2:51 AM | americanbankingnews.com

PolyPid price target raised to $10 from $9 at Roth Capital

August 14 at 6:21 PM | msn.com

PolyPid Releases Mid-2025 Financial Update

August 14 at 6:21 PM | theglobeandmail.com

PolyPid Reports Strong Phase 3 Results and Financial Update

August 14 at 10:27 AM | msn.com

PolyPid Ltd. (NASDAQ:PYPD) Q2 2025 Earnings Call Transcript

August 14 at 10:27 AM | msn.com

PolyPid Ltd (PYPD) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Rising Expenses

August 14 at 10:27 AM | finance.yahoo.com

PolyPid Ltd. (PYPD) Q2 2025 Earnings Call Transcript

August 13 at 5:04 PM | seekingalpha.com

PolyPid sees cash runway ‘well into’ 2026

August 13 at 2:01 PM | msn.com

PolyPid Reports Positive Phase 3 Results and Strengthens Leadership

August 13 at 8:17 AM | tipranks.com

PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results

August 13 at 7:30 AM | globenewswire.com

PolyPid Ltd.: PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer

August 12 at 5:57 PM | finanznachrichten.de

PolyPid appoints Tweezer-Zaks as Chief Medical Officer

August 12 at 5:57 PM | msn.com

PolyPid Appoints New Chief Medical Officer Amid Strategic Advancements

August 12 at 5:57 PM | msn.com

PolyPid Ltd. Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer

August 12 at 9:00 AM | quiverquant.comQ

PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer

August 12 at 8:00 AM | globenewswire.com

PolyPid Ltd. (NASDAQ:PYPD) Given Average Rating of "Buy" by Brokerages

August 6, 2025 | americanbankingnews.com

PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025

July 30, 2025 | globenewswire.com

PYPD: Positive Topline Data From D-PLEX₁₀₀ Trial Contributes to Multiple Subsequent Benefits

July 16, 2025 | finance.yahoo.com

PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the Diabetes and Weight Loss Market

July 15, 2025 | finance.yahoo.com

PolyPid Launches Long-Acting GLP-1 Delivery Platform for Diabetes Market

July 15, 2025 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CODX, PYPD, POCI, and COCH Company Descriptions

Envoy Medical NASDAQ:COCH

$1.46 -0.02 (-1.35%)

Closing price 08/14/2025 04:00 PM Eastern

Extended Trading

$1.46 0.00 (0.00%)

As of 08/14/2025 07:51 PM Eastern

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Co-Diagnostics NASDAQ:CODX

$0.27 +0.00 (+0.91%)

Closing price 08/14/2025 04:00 PM Eastern

Extended Trading

$0.36 +0.10 (+36.40%)

As of 08:00 AM Eastern

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Precision Optics NASDAQ:POCI

$4.71 +0.06 (+1.27%)

As of 08/14/2025 04:00 PM Eastern

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

PolyPid NASDAQ:PYPD

$3.43 -0.06 (-1.72%)

Closing price 08/14/2025 04:00 PM Eastern

Extended Trading

$3.51 +0.08 (+2.45%)

As of 07:00 AM Eastern

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time